EcoR1 Capital as of Dec. 31, 2014
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 22 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kite Pharma | 12.8 | $25M | 438k | 57.67 | |
| Clovis Oncology | 10.9 | $22M | 384k | 56.00 | |
| Receptos | 9.0 | $18M | 146k | 122.51 | |
| Array Biopharma Inc note 3.000% 6/0 | 8.2 | $16M | 18M | 0.93 | |
| Macrogenics (MGNX) | 8.1 | $16M | 454k | 35.07 | |
| Ironwood Pharmaceuticals (IRWD) | 7.0 | $14M | 900k | 15.32 | |
| Fibrogen | 5.5 | $11M | 400k | 27.34 | |
| Atara Biotherapeutics | 5.1 | $10M | 385k | 26.31 | |
| Kindred Biosciences | 4.9 | $9.6M | 1.3M | 7.45 | |
| Sage Therapeutics (SAGE) | 4.6 | $9.1M | 491k | 18.47 | |
| Keryx Biopharmaceuticals | 4.2 | $8.3M | 589k | 14.15 | |
| Assembly Biosciences | 4.0 | $7.9M | 1.0M | 7.86 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $6.5M | 328k | 19.75 | |
| Genvec | 2.1 | $4.1M | 2.0M | 2.08 | |
| Calithera Biosciences | 2.1 | $4.1M | 202k | 20.20 | |
| Vitae Pharmaceuticals | 1.7 | $3.4M | 207k | 16.64 | |
| Oncomed Pharmaceuticals | 1.7 | $3.4M | 157k | 21.76 | |
| Paratek Pharmaceuticals | 1.5 | $3.0M | 79k | 38.55 | |
| Forward Pharma A/s | 1.1 | $2.1M | 100k | 20.83 | |
| Targacept | 0.8 | $1.6M | 620k | 2.63 | |
| Halozyme Therapeutics (HALO) | 0.8 | $1.6M | 161k | 9.65 | |
| Array BioPharma | 0.6 | $1.1M | 228k | 4.73 |
